Skip to main content
AminoKinetics
Amino AxiomGlossaryResearch Tools

Amino Axiom Glossary FAQ for Growth-Factor Research

On this page

What is the Amino Axiom glossary?

The glossary is a feature of Amino Axiom, a free research information and tracking platform. It collects plain-language definitions of terms used in peptide research, with one page per term. The index is at Amino Axiom's glossary, and the platform's homepage is aminoaxiom.com.

Growth-factor and receptor-binding work draws vocabulary from several fields at once. A single paper may use terms from structural biology, assay kinetics, and analytical chemistry within one paragraph. This FAQ explains what a glossary entry offers and how a researcher in this lane might read it. It describes the feature as a reference for language and does not address the use of any material.

What does a glossary entry show?

An entry names the term, defines it in a few plain sentences, and places it in context so a reader can tell which part of research it belongs to. The aim is to make a paper or a catalog listing legible to someone who has not worked in that exact subfield. Entries describe vocabulary only. They do not evaluate compounds, rank suppliers, or describe how any material is handled.

The practical value is speed. A researcher reading a binding paper who meets an unfamiliar abbreviation can open the entry, confirm the meaning, and return to the paper. That is a small saving each time, and it adds up over a long reading list.

Why does growth-factor research lean on shared definitions?

Because the same word is used loosely across subfields. "Analog" can mean a point-substituted version of a native sequence, and "modified" can mean a chemical attachment rather than a sequence change. In ligand-binding work, "trap" and "antagonist" are not interchangeable: a trap sequesters a ligand directly, while an antagonist acts at the receptor. When two papers use one word differently, the comparison between them quietly breaks.

A fixed definition does not settle every ambiguity, but it gives a reader a stable reference point. That matters most for terms that appear in catalog listings, where a short phrase carries a lot of meaning.

How does the glossary help read a catalog listing?

A listing packs several kinds of information into a few lines: an identifier, a mass, a formula, a purity statement, and a storage note. The glossary explains what each of those fields is. Take IGF-1 LR3 as an example. The Amino Kinetics catalog records a molecular weight of 9117.5 g/mol, the formula C400H625N111O115S9, and CAS number 946870-92-4. Each is a different kind of fact.

Term What it is IGF-1 LR3 catalog value
CAS number Registry identifier for a substance 946870-92-4
Molecular weight Calculated mass of the molecule 9117.5 g/mol
Molecular formula Count of each element in the molecule C400H625N111O115S9
Purity Stated fraction of the target compound in a lot 99%+

Reading the table, a researcher sees that the CAS number names the substance while the mass and formula describe its makeup. The purity line is a statement about a lot, not about the compound in general, which is why it is paired with batch documentation.

What does the glossary say about a ligand trap such as Follistatin?

A ligand trap is a binding protein that holds a signaling ligand directly, preventing it from engaging its receptor. Follistatin is the standard example in the TGF-β superfamily, where it is studied for binding activin, GDF-8, and some bone morphogenetic proteins. The catalog lists it under CAS 117628-82-7 and describes it as a recombinant protein, so no single molecular formula applies.

The reason this entry matters is contrast. Reading it next to the entry for a receptor-engaging analog shows why the two behave differently in a binding assay: one removes the ligand, the other acts at the receptor. A glossary definition cannot say how any particular preparation performs, but it can make that distinction clear before a researcher opens the primary literature.

What does PEGylated mean, and why does it need its own entry?

PEGylation is the attachment of a polyethylene glycol chain to a core molecule. It changes the effective size of the product without changing the underlying sequence. PEG-MGF shows the point well. The catalog lists a core peptide mass of 2867.2 g/mol, the formula C121H200N42O39, and CAS number 108174-48-7, and it notes that mass varies with the PEG chain.

That note is the reason the term deserves a definition. A reader who sees "2867.2 g/mol" without the caveat may assume it describes the whole product, when it describes only the core. The glossary explains the term so the caveat is understood, and the lot documentation remains the authority on what a specific batch contains.

Can a glossary definition verify what a lot contains?

No, and the limit is worth stating plainly. A definition explains what "purity" or "lyophilized" means. It does not report on any supplier, and it cannot tell a researcher what is in a given vial. Identity and purity belong to analytical documentation for a specific batch, such as a certificate of analysis and its supporting traces.

Used well, the glossary makes that documentation easier to read. A researcher who understands what a mass-spectrometry result or a purity percentage represents can judge a lot report more carefully. For a walkthrough of that documentation, see the analytical standards and sourcing guide.

Which other terms come up most often in growth-factor reading?

A few recur across nearly every paper. "Residue" counts the amino acids in a chain, so a sequence length is a residue count. "Ligand" is the molecule that engages a receptor or a binding protein. "Affinity" describes how tightly two molecules hold each other, and "kinetics" describes how quickly they bind and release. "Lyophilized" means freeze-dried, which is how the catalog lists these materials, stored at −20 °C.

Each of these has its own entry, and reading them in sequence builds a working vocabulary quickly. A researcher new to the TGF-β and IGF signaling spaces can cover the core terms in an afternoon and then read the primary literature with far fewer stops. The glossary adds nothing to the evidence in those papers, but it removes a layer of friction that has nothing to do with the science.

How should a researcher use the glossary alongside the literature?

As a first stop, not a last one. A definition orients the reader, and the primary source carries the evidence. A sensible habit is to look up each unfamiliar term the first time it appears, note the definition in a reading log, and then return to the paper. Recording the date is useful, since platform content can be updated.

For background on the growth-factor terms above in the setting of a specific compound, see the follistatin and activin signaling overview. The full research catalog is at all compounds. Any listing should be checked against the compound entry and its batch documentation before conclusions are drawn.

This article is provided for research and informational purposes only. The compounds discussed are research chemicals intended for laboratory use only. They are not drugs, supplements, or food, and are not intended to diagnose, treat, cure, or prevent any disease. Amino Kinetics does not sell products intended for human or animal use. Amino Axiom is an independent information platform, and its content does not constitute guidance on the use of any material. Researchers are responsible for compliance with all applicable local, state, and federal regulations governing the purchase and use of research materials.

Reference

Common questions

It contains plain-language definitions of terms used in peptide research, each on its own page. Entries explain vocabulary such as sequence length, analog, lyophilized, and CAS number so a reader can follow a paper or a compound listing. The glossary defines language and does not describe the use of any material.